Ashwood P et al. 2010. Altered T cell responses in children with autism. Brain Behav Immun. PMID: 20833247

Bailey A, et al., 1995. Autism as a strongly genetic disorder – evidence from a British twin study. Psychol Med 25:63–77.

Barger BD. et al. 2012. Prevalence and onset of regression within autism spectrum disorders: a meta-analytic review. JADD. August 2012.

Barger SW et al., 2007. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation. J Neurochem. 101(5):1205-13.

Baron-Cohen, S et al., 2014. Elevated fetal steroidogenic activity in autism. Molecular Psychiatry 20:369–376. DOI: 10.1038/mp.2014.48

Bauer AZ and D Kriebel. 2013. Prenatal and perinatal analgesic exposure and autism: an ecological link. Environ Health. 12:41. doi: 10.1186/1476-069X-12-41.

Brett D et al., 2016. Factors affecting age at ASD diagnosis in UK: no evidence that diagnosis age has decreased between 2004 and 2014. J Autism Dev Disord. 46(6):1974-84. doi: 10.1007/s10803-016-2716-6.

Cannon DS et al., 2010. Genome-wide linkage analyses of two repetitive behavior phenotypes in Utah pedigrees with autism spectrum disorders. Mol Autism. 1(1):3. doi: 10.1186/2040-2392-1-3.

Carayol J et al., 2011. Autism risk assessment in siblings of affected children using sex-specific genetic scores. Mol Autism. 2(1):17. doi: 10.1186/2040-2392-2-17.

Feinberg JI et al., 2015. Paternal sperm DNA methylation associated with early signs of autism risk in an autism-enriched cohort Int J Epidemiol. 44(4):1199-210. doi: 10.1093/ije/dyv028.

Freitag CM. 2007. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12:2–22.

Fombonne E. 2003. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord. 33(4):365-82.

Frisch M, Simonsen J. 2015. Ritual circumcision and risk of autism spectrum disorder in 0- to 9-year-old boys: national cohort study in Denmark. J R Soc Med. 108(7):266-79. doi: 10.1177/0141076814565942.

Gerdts JA et al., 2013. The broader autism phenotype in simplex and multiplex families. J Autism Dev Disord.;43(7):1597-605. doi: 10.1007/s10803-012-1706-6.

Glasson EJ et al., 2004. Perinatal factors and the development of autism: a population study. Arch Gen Psychiatry. 61(6):618-27.

Godefroy D et al., 2012. The chemokine CCL2 protects against methylmercury neurotoxicity. Toxicol Sci. 125(1):209-18. doi: 10.1093/toxsci/kfr252.

Green-Snyder L et al., 2016. Autism spectrum disorder, developmental and psychiatric features in 16p11.2 duplication. J Autism Dev Disord. 46(8):2734-48. doi: 10.1007/s10803-016-2807-4.

Hanson E et al. 2015. The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. Biol Psychiatry 77(9):785-93. doi: 10.1016/j.biopsych.2014.04.021.

Hara M et al. 2015. De novo SHANK3 mutation causes Rett syndrome-like phenotype in a female patient. Am J Med Genet A. 167(7):1593-6. doi: 10.1002/ajmg.a.36775.

Hippolyte L et al., 2016. The number of genomic copies at the 16p11.2 locus modulates language, verbal memory, and inhibition. Biol Psychiatry. 80(2):129-39. doi: 10.1016/j.biopsych.2015.10.021.

Hu J et al., 2016. Low dose acetaminophen induces reversible mitochondrial dysfunction associated with transient c-Jun N-Terminal kinase activation in mouse liver. Toxicol Sci. 2016 Mar;150(1):204-15. doi: 10.1093/toxsci/kfv319.

Isles AR et al., 2016. Parental origin of interstitial duplications at 15q11.2-q13.3 in schizophrenia and neurodevelopmental disorders. PLoS Genet. 12(5):e1005993. doi: 10.1371/journal.pgen.1005993.

Kanne SM and Mazurek MO. 2011. Aggression in children and adolescents with ASD: prevalence and risk factors. J Autism Dev Disord. 41(7):926-37. doi: 10.1007/s10803-010-1118-4.

King M, Bearman P 2009. Diagnostic change and the increased prevalence of autism. Int J Epidemiol. 38(5):1224-34.

Le Couteur A, et al. 1996. A broader phenotype of autism: the clinical spectrum in twins. J Child Psychol Psychiatr Allied Disc 37:785–801

Loke YJ et al. 2015. The role of epigenetic change in autism spectrum disorders. Front Neurol. 6:107. doi: 10.3389/fneur.2015.00107.

Lopez-Hernandez, T. et al. 2011. Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly and macrocephaly with retardation and autism. Am J Hum Genet, 88(4): p. 422-32.

Li X et al. 2009. Elevated immune response in the brain of autistic patients. J Neuroimmunol. 207(1-2):111-6. doi: 10.1016/j.jneuroim.2008.12.002.

Maezawa I et al., 2011. Does microglial dysfunction play a role in autism and Rett syndrome? Neuron Glia Biol. 7(1):85-97. doi: 10.1017/S1740925X1200004X.

Marrosu F et al., 1987. Paradoxical reactions elicited by diazepam in children with classic autism. Funct Neurol. 2(3):355-61.

McBride K et al., 2010. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly. Autism Res. 3(3):137-41. doi: 10.1002/aur.132.

McCanlies EC et al., 2012. Parental occupational exposures and autism spectrum disorder. J Autism Dev Disord. 42(11):2323-34. doi: 10.1007/s10803-012-1468-1.

Molloy CA et al. 2006. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol. 172(1-2):198-205.

Mottron L 2015. Sex differences in brain plasticity: a new hypothesis for sex ratio bias in autism. Mol Autism. 6:33. doi: 10.1186/s13229-015-0024-1.

Philippe A et al., 2015. Case report: an unexpected link between partial deletion of the SHANK3 gene and Heller’s dementia infantilis, a rare subtype of autism spectrum disorder. BMC Psychiatry. 15:256. doi: 10.1186/s12888-015-0631-6.

Pino-López M, Romero-Ayuso DM. 2013. [Parental occupational exposures and autism spectrum disorder in children]. Rev Esp Salud Publica. 87(1):73-85. doi: 10.4321/S1135-57272013000100008.

Ratey JJ et al., 1987. Autism: the treatment of aggressive behaviors. J Clin Psychopharmacol. 7(1):35-41.

Sato D et al., 2012. SHANK1 Deletions in males with autism spectrum disorder. Am J Hum Genet. 90(5):879-87. doi: 10.1016/j.ajhg.2012.03.017.

Shenouda et al., 2015. Prevalence of Regressive Autism from 2000 to 2010: Findings from a Population-Based System. ISNAR Meeting, May 13-16.

Shetreat-Klein M 2014. Abnormalities of joint mobility and gait in children with autism spectrum disorders. Brain Dev. 36(2):91-6. doi: 10.1016/j.braindev.2012.02.005.

Spinelli L et al., 2015. Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes. J Med Genet. 52(2):128-34. doi: 10.1136/jmedgenet-2014-102803.

Stoch YK et al., 2012. Are prenatal ultrasound scans associated with the autism phenotype? Follow-up of a randomised controlled trial. J Autism Dev Disord. 201422 Dec;42(12):2693-701. doi: 10.1007/s10803-012-1526-8.

Theoharides TC et al. 2105. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders. J Neuroimmunol. 279:33-8. doi: 10.1016/j.jneuroim.2014.12.003.

Torres AR et al., 2003. Is fever suppression involved in the etiology of autism and neurodevelopmental disorders? BMC Pediatr. 3:9.

Wenger TL et al., 2016. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening. Mol Autism. 7:27. doi: 10.1186/s13229-016-0090-z. eCollection 2016.

Westphal A. et al. 2012. Revisiting regression in autism: Heller’s “Dementia Infantilis.” JADD. 43(2):265-71. doi: 10.1007/s10803-012-1559-z.

Yazbak FE. 2003. Autism in the United States: A perspective. J Am Physicians Surg. 8:103–7

• Uncategorized